New research hints at a way to delay Alzheimer’s symptoms
Ongoing research hints at delaying Alzheimer’s symptoms in genetically predisposed individuals using an experimental anti-amyloid drug. The study, led by Washington University in St. Louis, faces funding challenges amidst NIH internal changes.